These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30539587)

  • 1. Detection of Autoantibodies to Complement Components by Surface Plasmon Resonance-Based Technology.
    Noe R; Chauvet S; Togarsimalemath SK; Marinozzi MC; Radanova M; Vasilev VV; Fremeaux-Bacchi V; Dragon-Durey MA; Roumenina LT
    Methods Mol Biol; 2019; 1901():271-280. PubMed ID: 30539587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Anti-C3b Autoantibodies by ELISA.
    Radanova M; Roumenina LT; Vasilev V
    Methods Mol Biol; 2021; 2227():133-139. PubMed ID: 33847938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against complement components and functional consequences.
    Dragon-Durey MA; Blanc C; Marinozzi MC; van Schaarenburg RA; Trouw LA
    Mol Immunol; 2013 Dec; 56(3):213-21. PubMed ID: 23790637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.
    Józsi M; Reuter S; Nozal P; López-Trascasa M; Sánchez-Corral P; Prohászka Z; Uzonyi B
    Immunol Lett; 2014 Aug; 160(2):163-71. PubMed ID: 24491679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against alternative complement pathway proteins in renal pathologies.
    Nozal P; López-Trascasa M
    Nefrologia; 2016; 36(5):489-495. PubMed ID: 27267919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.
    Defendi F; Thielens NM; Clavarino G; Cesbron JY; Dumestre-Pérard C
    Clin Rev Allergy Immunol; 2020 Apr; 58(2):229-251. PubMed ID: 31834594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme.
    Halbwachs L; Leveillé M; Lesavre P; Wattel S; Leibowitch J
    J Clin Invest; 1980 Jun; 65(6):1249-56. PubMed ID: 6902727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis.
    Vasilev VV; Noe R; Dragon-Durey MA; Chauvet S; Lazarov VJ; Deliyska BP; Fremeaux-Bacchi V; Dimitrov JD; Roumenina LT
    J Biol Chem; 2015 Oct; 290(42):25343-55. PubMed ID: 26245903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-factor H Autoantibodies Assay by ELISA.
    Sénant M; Dragon-Durey MA
    Methods Mol Biol; 2019; 1901():191-196. PubMed ID: 30539578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.
    Blom AM; Corvillo F; Magda M; Stasiłojć G; Nozal P; Pérez-Valdivia MÁ; Cabello-Chaves V; Rodríguez de Córdoba S; López-Trascasa M; Okrój M
    J Clin Immunol; 2016 Jul; 36(5):517-27. PubMed ID: 27146825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecules Great and Small: The Complement System.
    Mathern DR; Heeger PS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1636-50. PubMed ID: 25568220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complement cascade and renal disease.
    Kościelska-Kasprzak K; Bartoszek D; Myszka M; Zabińska M; Klinger M
    Arch Immunol Ther Exp (Warsz); 2014 Feb; 62(1):47-57. PubMed ID: 24030732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-factor B autoantibody in dense deposit disease.
    Strobel S; Zimmering M; Papp K; Prechl J; Józsi M
    Mol Immunol; 2010 Apr; 47(7-8):1476-83. PubMed ID: 20193965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice.
    Sekine H; Reilly CM; Molano ID; Garnier G; Circolo A; Ruiz P; Holers VM; Boackle SA; Gilkeson GS
    J Immunol; 2001 May; 166(10):6444-51. PubMed ID: 11342671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C; Licht C; Mengel M; Uzonyi B; Strobel S; Zipfel PF; Józsi M
    Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
    Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
    J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against complement components in systemic lupus erythematosus - role in the pathogenesis and clinical manifestations.
    Hristova MH; Stoyanova VS
    Lupus; 2017 Dec; 26(14):1550-1555. PubMed ID: 29092674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of CRP Autoantibodies by SPR Immunoassay.
    Li QY; Li HY
    Methods Mol Biol; 2019; 1901():205-219. PubMed ID: 30539580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome.
    Sartz L; Olin AI; Kristoffersson AC; Ståhl AL; Johansson ME; Westman K; Fremeaux-Bacchi V; Nilsson-Ekdahl K; Karpman D
    J Immunol; 2012 Feb; 188(4):2030-7. PubMed ID: 22250080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in haemolytic uraemic syndrome (HUS).
    Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.